Akebia Therapeutics, Inc. Company Information
Overview
Akebia Therapeutics, Inc. is located in MA. Akebia Therapeutics, Inc. mainly operate in the Drugs, Proprietaries, and Sundries industry. Currently they have estimated 11–50 employees.
Website:
- http://www.akebia.com
Size:
-
11–50 employees
Headquarters:
- 245 1st St, MA 02142
Phone Number:
-
Fax
-
Fax
Industry:
-
Drugs, Proprietaries, and Sundries
Founded:
-
2007
Employees at Akebia Therapeutics, Inc.
Showing 10 of 20| JOB TITLE | WORK EMAIL | WORK PHONE | LOCATION | |
|---|---|---|---|---|
| Vice President and General Counsel | Hadas, Ilam | |||
| Vice President, Investor Relations and Corporate Communications At Akebia | Boston, Massachusetts | |||
| Cmo, Executive Vice President, and Co-Founder | Columbus, Ohio | |||
| Cso and Vice President Research and Development | Peters, Michigan | |||
| Senior Vice President and Cso | Boston, Massachusetts | |||
| Employee | Raleigh, North Carolina | |||
| Senior Vice President, Cfo and Treasurer | Boston, Massachusetts | |||
| President and Ceo | Cincinnati, Ohio | |||
| Employee | Butler, Pennsylvania | |||
| President and Ceo |
Vice President and General Counsel
Hadas, Ilam Vice President, Investor Relations and Corporate Communications At Akebia
Boston, Massachusetts Cmo, Executive Vice President, and Co-Founder
Columbus, Ohio Cso and Vice President Research and Development
Peters, Michigan Senior Vice President and Cso
Boston, Massachusetts Employee
Raleigh, North Carolina Senior Vice President, Cfo and Treasurer
Boston, Massachusetts President and Ceo
Cincinnati, Ohio Employee
Butler, Pennsylvania President and Ceo
Enter an employee name to search and verify work emails, phone numbers and social links etc.
Akebia Therapeutics, Inc.'s Email Format
We found 5 email formats used by Akebia Therapeutics, Inc. employees. The most common Akebia Therapeutics, Inc. email format is first_initial last ex.(jdoe@akebia.com) being used 93% of the time.
first_initial last
93%
others
3%
first
2%
first.last
1%
first last_initial
1%